M&T Bank Corp Bristol Myers Squibb CO Call Options Transaction History

M&T Bank Corp

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $7,708 - $9,198	-159 Reduced 97.55%	4 $0
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $231 - $258	4 Added 2.52%	163 $9,000
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $1,656 - $1,839	-26 Reduced 14.05%	159 $10,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $12,156 - $13,788	185 New	185 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $17 - $10,603	138 Added 50.92%	409 $71,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $726 - $799	-10 Reduced 3.56%	271 $15,000
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $1,291 - $1,548	21 Added 8.08%	281 $108,000
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $429 - $500	8 Added 3.17%	260 $51,000
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $118 - $138	2 Added 0.8%	252 $18,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $10,091 - $10,989	163 Added 187.36%	250 $24,000
Q1 2021 May 06, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 1.16%	87 $7,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $2,194 - $2,486	38 Added 79.17%	86 $7,000
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $402 - $445	7 Added 17.07%	48 $7,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $934 - $1,219	19 Added 86.36%	41 $20,000
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $89 - $98	2 Added 10.0%	22 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $45 - $53	1 Added 5.26%	20 $1,000
Q2 2017 Aug 11, 2017	BUY	N/A	19	19 $3,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.